Literature DB >> 30831554

Distribution of multiple myeloma in India: Heterogeneity in incidence across age, sex and geography.

Kaustubh Bora1.   

Abstract

BACKGROUND: This study aimed to investigate the distribution of multiple myeloma (MM) in India and provide a comprehensive narrative about its incidence, including differential patterns across age, sex and geography.
METHODS: MM cases diagnosed during 2012-14 were obtained from 27 populations based cancer registries in India by consulting the latest National Cancer Registry Programme reports. Crude (CR) and age-specific (ASR) rates of MM incidence were determined. Age-adjusted rates (AARs) were estimated by standardizing the CR values using age-specific weights recommended for LMIC countries (including India) for men and women separately, along with the corresponding 95% confidence interval (95% CI) measures.
RESULTS: Altogether, 1916 MM cases (male/female: 1123/793) were documented (i.e. 1.19% of all cancers, 95% CI: 1.14-1.24%). Overall CR of MM in India was 1.27 (95% CI: 1.20-1.35)/ 100,000 in men and 0.95 (95% CI: 0.89-1.02)/ 100,000 in women, while the corresponding AARs were 1.13 (95% CI: 1.07-1.20) and 0.81 (95% CI: 0.75 - 0.88) per 100,000 respectively. The ASR values increased steadily with age. Most cases belonged to the 60-69 yrs bracket. However, regional and sex-specific differences in MM profile were observed. MM incidence was highest in the Southern and Northern zones, and least in the Northeast. The Northern and Central zones had higher proportion of MM in the 50-59 yrs age group, whereas Eastern zone had higher proportion of cases aged 70 yrs and above.
CONCLUSION: Incidence of MM in India is presented. Marked variations in MM incidence were noted with respect to age, sex and geography.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epidemiology; Haematological malignancy; Incidence; India; Monoclonal gammopathy; Multiple myeloma

Mesh:

Year:  2019        PMID: 30831554     DOI: 10.1016/j.canep.2019.02.010

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  5 in total

1.  A Multicenter Study of Clinical Presentations and Outcomes of Multiple Myeloma in Pakistan: The Real-World Analysis in a Resource-Constrained Country.

Authors:  Nadia Saeed; Usman Ahmad; Munira Moosajee; Zeeshan Ahmed Khan Niazi; Neelam Siddiqui; Zeba Aziz; Danish Hassan Khan; Faiza Iftikhar; Imran Nazir Ahmad; Muhammad Ayaz Mir
Journal:  Indian J Hematol Blood Transfus       Date:  2021-09-02       Impact factor: 0.900

2.  Cost of HSCT in a Tertiary Care Public Sector Hospital in India.

Authors:  Vinay Goel; Pankaj Arora; Pankaj Malhotra; Anil Kumar Gupta
Journal:  Indian J Hematol Blood Transfus       Date:  2021-03-08       Impact factor: 0.900

3.  Trends of incidence, mortality and survival of multiple myeloma in Spain. A twenty-three-year population-based study.

Authors:  D-Y-L Chang-Chan; R Ríos-Tamayo; M Rodríguez Barranco; D Redondo-Sánchez; Y González; R Marcos-Gragera; M J Sánchez
Journal:  Clin Transl Oncol       Date:  2021-01-12       Impact factor: 3.405

4.  Clinicopathological spectrum of solitary Plasmacytoma: a single center experience from coastal India.

Authors:  Sridevi Hanaganahalli Basavaiah; Flora D Lobo; Cheryl Sarah Philipose; Pooja K Suresh; Saraswathy Sreeram; Hema Kini; Kausalya K Sahu; Krishna Prasad
Journal:  BMC Cancer       Date:  2019-08-14       Impact factor: 4.430

5.  Quality of life assessment & out-of-pocket expenditure in multiple myeloma: An observational study.

Authors:  Anisha Mathew; Habib Hasan Farooqui; Lalit Kumar
Journal:  Indian J Med Res       Date:  2021-06       Impact factor: 5.274

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.